Is Mitragynine safe for babies and kids?
Very high risk for kidsInfants are more vulnerable to Mitragynine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What is mitragynine?
The IUPAC name is methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate.
Also known as: 4098-40-2, (-)-Mitragynine, 9-Methoxycorynantheidine, Skf 12711.
- IUPAC name
- methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
- CAS number
- 4098-40-2
- Molecular formula
- C23H30N2O4
- Molecular weight
- 398.5 g/mol
- SMILES
- CC[C@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC
- PubChem CID
- 3034396
Risk for babies
Very high riskInfants are more vulnerable to Mitragynine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Context-dependentPregnancy alters the metabolism and distribution of Mitragynine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Regulatory consensus
2 regulatory and scientific bodies have classified Mitragynine. The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| FDA | 2014 | Import Alert 54-15 — unapproved new drug; not GRAS | |
| DEA | 2016 | Drug and Chemical of Concern (not currently scheduled federally) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter mitragynine
- Natural Product
- Supplement
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Mitragynine:
-
Buprenorphine/naloxone (Suboxone)
Trade-offs: Prescription required. Partial opioid agonist. Well-studied safety profile. Diversion risk.Relative cost: $100-500/month
Frequently asked questions
Is mitragynine safe for kids?
Infants are more vulnerable to Mitragynine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What should I do if my child is exposed to mitragynine?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
See Mitragynine in the baby app
Look up products containing mitragynine, compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (1)
- —
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →